Aloe Vera is one of 104 small molecule programs targeting Type 2 Diabetes Mellitus. It is currently in Approved.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
676 competitors in Type 2 Diabetes Mellitus
Aloe Vera
Byetta
Insulin 320
Adenocard
NOVOLIN R
Cipro
Myrbetriq
Dostinex
Lantus
Precedex
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Sources
Details